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 ABSTRACT 
BACKGROUND  
The use of complementary and alternative medicine (CAM) has dramatically increased 
over the years since 1990. It is one of the fastest growing fields in healthcare and it is widely 
used today in the United States. Most people utilizing CAM approaches are seeking ways to 
improve overall health and well-being to relieve symptoms associated with body aches such as 
neck and back pain, stiffness, chronic illnesses, anxiety and depression, and side effects of 
conventional medicine. Symptoms of depression can lead to major depression, which is 
consequentially a major public health problem in the United States. In 2014, more than 1 out of 
20 Americans have been reported to have moderate/high depressive symptoms. While 
depression is treatable with western medication, many have found that the use of mind and 
body approaches such as mediation, chiropractic/osteopathic manipulation, and yoga show 
great benefit in improving the cognitive symptoms of depression without medication side 
effects. 
OBJECTIVES 
The objective of this study was to assess the association between the use of mind-body 
therapy and depressive symptoms. The analyses presented focus on determining whether 
mind-body therapy users are more or less likely to be depressed.   
METHODS 
 This study used a secondary and cross-sectional data from the 2012 National Health 
Interview Survey, a nationally representative household interview survey. The Adult Sample 
and the Adult Alternative datasets were used, and consisted of 34,525 participants. The sample 
 was exclusive to adults ≥ 18 years of age. Analyses were conducted with 11,143 adults with 
depressive symptoms. The dependent variables were defined as self-reported response of 
emotional distress, the independent variable as Mind-Body Therapies users. SAS 9.4 was used 
to conduct descriptive, binomial, multinomial logistic regression analyses, and generalized 
linear mixed model. The level of significance of 0.05 was used to determine statistical 
significance.  
RESULTS 
In the weighted unadjusted model, the association between the use of at least one 
mind-body therapy and depressive symptoms was statistically significant, with an odd ratio of 
1.51 and 95% CI (1.26, 1.81). The number of mind-body therapies used [OR= 1.13, 95% CI (1.09, 
1.17)] and the most commonly used mind-body therapies [OR= 1.51, 95% CI (1.27. 1.81)] also 
yielded statistically significant association with depressive symptoms. In the weighted adjusted 
binomial logistic regression model, only the number of mind-body therapies used [OR=1.09, 
95% CI (1.06, 1.18)] yielded a statistically significant association with depressive symptoms.  
CONCLUSION 
 A negative association was found between the use of mind-body therapy and mental 
health among U.S. adults in all unadjusted models. Mind-body therapies users were found to be 
more depressed individuals. These results support the literature reviews that mind-body 
therapies users are more likely to be depressed. 
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INTRODUCTION 
Complementary and Alternative Medicine (CAM) is a group of diverse medical and 
healthcare systems and products, referred to as a non-mainstream Western (NIH, 2016). It is 
often categorized into two subgroups: mind and body practices such as meditation, yoga, 
chiropractic/osteopathic manipulation, and natural products such as supplements and herbs 
(NIH, 2016).   
The first nationally representative survey on the use of CAM was first conducted in 
1990, where prevalence, costs, and patterns of the use of CAM were analyzed (Institute of 
Medicine, 2005).  Results from the survey indicated that Americans spent an annual 
approximate of $10.3 billion out of pocket on CAM, in comparison with an annual approximate 
cost of $12.8 for all hospitalizations in the United States (Institute of Medicine, 2005). A follow-
up survey was conducted and indicated an increase in the prevalence of CAM usage by 25% 
from 1990 to 1997 (Institute of Medicine, 2005). In 2002, the National Health Interview Survey, 
which conducts a study on the health of the nation since 1957, started including questions 
regarding CAM usage (NIH, 2017). Today, NHIS survey includes questions regarding CAM usage 
every five years.  
 CAM is one of the fastest growing fields in healthcare and is widely used today in the 
United States. The use of CAM has become prevalent over the past years with approximately 
38.3% of adults in the United States reported using CAM in 2007 (Hernandez- Reif, Horton, 
Vaughn, Pollard, Juarez, Kendrick, & Burns-Nader, 2015; NIH, 2017). Most people utilizing CAM 
approaches are seeking ways to improve overall health and well-being to relieve symptoms 
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associated with body aches such as neck and back pain, stiffness, chronic illnesses, anxiety and 
depression, and side effects of conventional medicine (Barnes, & Bloom, 2008). 
 The popularity of mind and body practices has significantly grown over the years, 
especially yoga, where the number of people practicing yoga doubled in 2012 (NIH, 2016). The 
2012 NHIS define mind-body practices as yoga, meditation, chiropractic and osteopathic 
manipulation, meditation and massage therapy as the most popular mind and body practices 
used by adults (NIH, 2016). Other mind-body therapies include acupuncture, guided imagery, 
tai chi, qi gong, Pilates, progressive relaxation, Alexander techniques, and Trager psychophysical 
integration (NIH, 2016). Although the amount of research varies depending on the type of CAM, 
there have been many studies which have documented the health benefits of practices such as 
yoga, meditation and acupuncture (NIH, 2016). CAM users were found to practice mind-body 
therapies, especially meditation for mental health, behavioral self-regulation, and integrative 
medical care (Burke, Lam, Stussman, & Yang, 2017). Today, many accredited medical schools 
have begun introducing mindfulness-based interventions in their academic curriculum (Barnes, 
Hattan, Black, & Schuman-Olivier, 2016). Incorporating mind-body integrative medicine within 
medical training and residency programs not only increases options for patients care but also 
medical field’s research and practices, which can potentially benefit physician and patients in 
the future (Barnes, Hattan, Black, & Schuman-Olivier, 2016). 
 Most people seek out CAM modalities due to mental health problems such as 
depression, anxiety, and stress (Pilkington, Kirkwood, Rampes, & Richardson, 2005). Depression 
is one of the most common but serious mental disorders in the United States (NIH, 2016). In 
2014, more than 1 out of 20 Americans were reported to have moderate to high depressive 
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symptoms (CDC, 2014). An individual who suffers from depression is also more likely to suffer 
from anxiety disorder or vice versa. Anxiety disorders affect approximately 18.1% of the U.S. 
population every year (Anxiety and Depression Association of America, 2017). Although both 
depression and anxiety are highly treatable, many individuals do not seek treatment (ADAA, 
2017). While there is growing scientific evidence about CAM, it is often recommended to use 
CAM as a complement to conventional medicine to treat mental illnesses such as depression 
and anxiety disorder (ADAA, 2017). While CAM is often recommended as a complement to 
conventional medicine, physicians often do not recommend using St. John’s Wort with certain 
antidepressants as it can lead to life-threatening increase of serotonin (NIH, 2017).  A major 
concern with CAM usage is that many people do not consult with a mental health provider or 
primary care physician before selecting CAM modalities or discontinuing conventional medicine 
(ADAA, 2017).  
 Most findings in the literature with respect to the effect of mind and body practices on 
depressive symptoms consistently report potential benefits for mental health. However, 
questions remain about which therapies and/ or which combination of therapies are most 
effective, and what intensity and frequency a therapy needs to be used in order to see effect on 
mental health related symptoms. The analysis presented focuses on selected mind and body 
approaches in NHIS 2012 and its relationship with depressive symptoms.  
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REVIEW OF THE LITERATURE 
Depressive Symptoms   
Depressive symptoms are defined as the feeling of sadness, emptiness, hopelessness, 
and anxiety (Mirowsky & Ross, 2002). These feelings are often a normal response to life’s 
stressors, and most people have sad mood at some point in life (National Institute of Mental 
Health, 2016). However, a persisting emotion of sadness or loneliness that interferes with daily 
life may become a severe condition. Many prior studies use the terms “depressive symptoms” 
and “depression” interchangeably as depressive symptoms are part of the feelings of 
depression. Depression is a serious medical illness that causes inability to function at work and 
home (National Institute of Health, 2016). Major depressive disorder is the leading cause of 
disability, affecting approximately 6.7% of the U.S. population age 18 and older (ADAA, 2017). 
Studies suggested that genetic, biological, environmental, and psychological factors are the 
main causes of depression (NIH, 2016). Depression can occur at any age; however, studies have 
found that the prevalence of depression increases with age (NIH, 2016; Fekadu, Shibeshi, & 
Engidawork, 2017). Women are also more likely to be diagnosed with depression than men. 
One of the reasons is that men and women may perceive “depression” differently. Men often 
feel depressed based on tiredness, irritability, and anger; while women define depressed as 
sadness, worthlessness, and guilt (National Institute of Mental Health, 2016). The leading cause 
of depression is often associated with other conditions and behaviors, including other mental 
disorders such as anxiety disorder, and chronic conditions such as arthritis and asthma. 
(Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015; American Psychiatric Association, 2013). 
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When depression is not adequately treated, it can become a severe chronic disease (Greenberg, 
et al., 2015; American Psychiatric Association, 2013). 
Depression in Older Adults  
 The risk of depression increases with age (CDC, 2017), in part because of the 
psychological/emotional impact of one’s to deteriorating condition of health. The prevalence 
rate of depression varies considerably depending on several factors. For example, the 
prevalence of depression in community sampled adults age 65 and older ranges from 1% to 5%, 
and increases for those living in home healthcare and hospital to 13.5% and 11.5% respectively 
(CDC, 2017). Although major depression is not prevalent in late life, recent meta-analyses 
showed that the prevalence of clinical depressive symptoms is high in older adults, with rates 
for sub-threshold depressive symptoms (those failing to reach diagnostic criteria) ranged from 
4.5% to 37.4%. (Rodda, Walker, & Carter, 2011). It appears that older adults are more likely to 
experience depression with less independence or a greater medical assistance need 
environment.  
 There are two types of age of onset of disorder: early-onset depression and late-onset 
depression. For individuals who have already experienced mental illness earlier in life, this is 
referred to as early-onset depression; while those whose first encounter with mental illness in 
old age is called late-onset depression (Fiske, Wetherell, & Gatz, 2009). More than half of the 
older adults are diagnosed with depression in old age, and less than half are diagnosed before 
old age (Brodaty, Luscombe, Parker, Wilhelm, Hickie, Austin, & Mitchell, 2001). Early onset 
depression was found to be related to family history of depression (Heun, Papassotiropoulos, 
Jessen, Maier, & Breitner, 2001). The leading cause of late-life depression consists of a complex 
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multidirectional interaction of biologic, psychological and social factors (Rehan, & Steffens, 
2014).  
Depression in older adults has become a serious public health concern as the number of 
older adults increased by 15.1% between 2000 and 2010 (Rehan, & Steffens, 2014). Treatments 
for depression in old age include behavioral therapy, cognitive-behavioral therapy, cognitive 
bibliotherapy, problem-solving therapy, brief psychodynamic therapy, and life review/ 
reminiscence therapy (Fiske, et al., 2009). 
Chronic Conditions and Depressive Symptoms 
 Depression can occur along with other serious illness, such as diabetes, cancer, heart 
diseases, etc. Depression can make these conditions worse and vice versa. Studies showed that 
individuals with chronic diseases and comorbid depression reported significantly higher 
numbers of medical symptoms compared to those with only chronic illness alone (Katon, Lin, & 
Kroenke, 2007). The risk of depression increases between 25-33% with chronic illnesses 
(Morewitz, 2006). Depression is difficult to diagnose in clinical diagnosis because feeling 
depressed is often assumed to be normal for an individual dealing with a serious chronic 
disease (Morewitz, 2006). In addition, physical symptoms of depression such as disturbed sleep, 
impaired appetite, and lack of energy may be a result of an already existing disease (Turner, & 
Kelly, 2000). The most common chronic conditions associated with depression include arthritis, 
asthma, diabetes, cancer, coronary heart disease (CHD), chronic obstructive pulmonary disease 
(COPD), stroke, and obesity/BMI (Chapman, Perry, & Strine, 2005). While all these chronic 
conditions are manageable with medications, side effects are a concern as it may affect 
patients’ mood and trigger depression (NIH, 2017). These chronic illnesses’ therapeutic 
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treatment may be beneficial to target a specific condition, but with comorbid depression, the 
treatment may harm the patients.  
Arthritis 
 Arthritis is a leading cause of disability in the United States, affecting 54.4 million of 
adults (CDC, 2017). It is one of the most common chronic condition and a common cause of 
chronic pain. According to CDC’s definition, arthritis includes more than 100 disease and 
conditions, including osteoarthritis, rheumatoid arthritis, fibromyalgia, gout, and lupus. Patients 
may experience joint pain, aching, stiffness, and swelling. Rheumatoid arthritis (RA) seem to be 
the most common type of arthritis associated with depression (Dickens, McGowan, Clark- 
Carter, & Creed, 2002; Covic, Cumming, Pallant, Manolios, Emery, Conaghan, & Tennant, 2012). 
Depression was found to be highly prevalent in RA and associated with poorer RA outcomes 
such as increased pain, more comorbidities, and increased mortality levels (Matcham, Rayner, 
Steer, & Hotopf, 2013). 
Asthma 
 Asthma is a chronic lung disease that inflames and narrows the airways and affects 
more than 22.2 million people in the US (NIH, 2014; Anupama, Bollinger, & Teodor, 2008). 
Asthma has often been considered an illness in which mood and emotions contribute to 
symptom exacerbation (Zielinski, Brown, Nejtek, Khan, Moore, & Rush, 2000). Although mood 
disorders are common among asthma patients, these symptoms are often unrecognized and 
untreated (Nejtek, Brown, Khan, Moore, Wagner, & Parantie, 2001). Asthma is often controlled 
through pharmacotherapy: controller medication, which is taken on a daily basis, and rescue 
medication, which is used for acute exacerbations (Kewalramani, Bollinger, & Postolache, 
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2009). Although these treatments are useful for treating asthma, adverse events such as 
exacerbations of depression or anxiety symptoms need to be monitored closely (Kewalramani, 
Bollinger, & Postolache, 2009). The prevalence of depressive disorders among individuals with 
asthma is not well determined, however, several studies have found that depression may 
increase the risk of death among asthma patients or that depression is associated with an 
increase of asthma symptoms. These results are not consistent as other studies have found no 
correlation between diagnosis of depression and asthma (Zielinski, et al., 2000). 
Cancer 
 Cancer is life-threatening and a feared diagnosis. A cancer diagnosis is a stressful, and 
life-changing event that can impact most patients, family, and friends, emotionally. Feelings of 
depression such as hopelessness, helplessness, sadness, anger are very common among cancer 
patients (ACS, 2016). Depression affects more than 10% of patients among cancer patients 
(Smith, 2015). Therapeutic treatment such as antidepressant medication and psychological 
treatments can be used to manage depressive symptoms. However, these treatments may have 
different harms and benefits for cancer patients (Walker, Sawhney, Hansen, & Ahmed, 2013). 
Diabetes 
The increased prevalence of depression among diabetes is reported in several 
community studies. Comorbid diabetes and depression are clinically challenging to treat as both 
conditions are worsened by one another (Holt, de Groot, & Golden, 2014). Diabetic patients 
have twice the risk of having depressive symptoms (Vickers et al., 2006), which can cause other 
complications such as diabetic retinopathy, skin complication, and swollen feet (American 
Diabetes Association, 2017). Type 2 diabetes patients who uses insulin were found to have a 
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higher rate of depression amongst those who takes noninsulin medication or dietary and 
lifestyle intervention only (Li, Ford, Strine, & Mokdad, 2007). Depression is frequently 
disregarded in people with diabetes due to the fact that both conditions may be driven by 
shared underlying biological and behavioral mechanism such as hypothalamic-pituitary-adrenal 
axis activation, inflammation, sleep disturbance, inactive lifestyle, poor dietary habits, and 
environmental and cultural risk factors (Holt, de Groot, & Golden, 2014). Treatment for 
depression such as psychological intervention and antidepressants are effective in treating 
depression but have mixed effects on glycemic control in diabetic patients (Holt, de Groot, & 
Golden, 2014). 
Coronary Heart Disease (CHD) 
 Heart disease is the leading cause of death in the United States with 1 out 4 people 
dying from it (CDC, 2017). Coronary Heart Disease is the most common type of heart disease, 
where plaques build up inside the coronary arteries and prevent oxygen-rich blood to the heart 
(NIH, 2016). Depression is a highly prevalent risk factor for CHD with 9.3% of individuals with 
cardiac disease compared to 4.8% with no comorbid disease (Edgede, 2007). A systematic 
review reported that 20% of CHD patients met criteria for a major depressive disorder, and 47% 
experienced depressive symptoms (Bush, Ziegelstein, Patel, Thombs, Ford, Fauerbach, & Bass, 
2005). Depression was also found to be three times as high after an acute myocardial infarction 
(AMI), especially among women (Thombs, Bass, Ford, Stewart, Tsilidis, Patel, Fauerbach, Bush, 
& Ziegelstein, 2006; Kessler, 2003; Pilote, Dasgupta, Guru, Humphries, McGrath, Norris, Rabi, 
Tremblay, Alamian, Barnett, Cox, Ghali, Grace, Hamet, Ho, Kirkland, Lambert, Libersan, 
O’Loughlin, Paradis, Petrovich, & Tagalakis, 2007). 
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Chronic Obstructive Pulmonary Disease (COPD) 
 Chronic Obstructive Pulmonary Disease is a very common lung disease that affects over 
30 million of Americans (COPD Foundation, 2017).  COPD has a significant impact on the quality 
of life such as restriction of activities, sleeping problems, and limitation of social life (Yohannes, 
& Alexopoulos, 2015). These restrictions highly affect mental health. Around 40% patients are 
affected by depressive symptoms or major depression (Stage, Middelboe, Stage, & Sorensen, 
2006). Depression contributes to a substantial burden to reduce adherence to treatment due to 
overlapping symptoms (Yohannes, & Alexopoulos, 2015; Stage, et al., 2006). 
Stroke 
 Although the comorbidity of stroke and depression has been understudied, post-stroke 
depression (PSD) is a concern that has often been overlooked and untreated (Narushima, & 
Robinson, 2002). Post-stroke depression is a common psychiatric disorder as a consequence of 
stroke, and it can greatly reduce the quality of life of a patient. According to epidemiological 
studies, one-third of patients experience early- or late-onset of depression (Gaete, & 
Bogousslavsly, 2014). Studies showed that 30% of patients experience minor depression and 
25% experience major depression following stroke (Alajbegovic, Djelilovic-Vranic, Alajbegovic, 
Nakicevic, Todorovic, & Tiric-Campara, 2014). Stroke patients with PSD suffer from higher 
mortality rate and slower functional recovery (Paolucci, 2008). PSD is often not diagnosed 
appropriately due to somatic symptoms caused by medical illness and cognitive impairment 
(Paolucci, 2008). PSD is potentially treatable; however, there has not been enough 
antidepressant agent or nonpharmacological interventions’ benefits observed (Gaete, & 
Bogousslavsly, 2014). 
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Underweight, Overweight and Obesity/ BMI 
   Obesity has long been a public health concern. It is a complex health issue that is 
associated with poor mental health, reduced quality of life, and it is the leading cause of death 
in the United States (CDC, 2017). It also contributes to diabetes, heart disease, stroke, and 
cancer (CDC, 2017). According to CDC, 43% of adults with depression are obese, and as the 
obesity rate increases, the severity of depressive symptoms also increases (CDC, 2014). In all 
age groups, women with depression were more likely to be obese than women without 
depression (CDC, 2014). Treatments and interventions are available for both conditions, and it 
was found that weight loss may improve mood (Society for the Study of Ingestive Behavior, 
2009).  
 Studies show that BMI classification (underweight, normal, overweight and obesity) and 
depression demonstrate a U-shaped relationship, where there is a higher prevalence of 
depression among underweight and obese patients (Carey, Small, Yoong, Boyes, Bisquera, & 
Sanson-Fisher, 2014).  
Physical and Strength activities and Depressive Symptoms 
 There is a substantial number of studies showing the positive effects of physical activity 
on mood, anxiety, and general well-being. Most depressed patients first seek treatment from 
their primary health care provider, where they receive pharmacologic therapy alone (Craft, & 
Perna, 2004). Behavioral interventions such as exercising has shown to reduce the risk of 
developing depression, and to alleviate symptoms of depression (O’Neal, Dunn, & Martinsen, 
2000). While most studies focused on the relationship between aerobic physical activity and 
depression, resistance-training has also been assessed and has shown to reduce symptoms of 
Page | 13  
 
depression as well (Craft, & Perna, 2004). Both aerobic exercise and strength training was found 
to be sufficient to reduce symptoms of depression (Craft, & Perna, 2004). Also, exercising was 
found to be comparable to standard care approaches, where individuals who met CDC’ s 
recommendation had a similar beneficial effect on depressive symptoms as antidepressant 
treatments (Dinas, Koutedakis, & Flouris, 2010).  
Mind-Body Therapies and Depressive Symptoms 
CAM modalities such as acupuncture, yoga, meditation, and stress and relaxation 
techniques have shown to decrease psychological distress, like depressive symptoms and 
anxiety (Deckro, Ballinger, Hoyt, Wilcher, Dusek, Myers, Greeberg, Rosenthal, & Benson., 2002). 
With the increased use of CAM, it was found that 24% adults who have anxiety/ depression use 
mind-body medicine therapies among the 34 million mind-body therapy users (D’Silva, 
Poscablo, Habousha, Kogan, & Kligler, 2012). Women are often found to practice mind-body 
therapies more often than men. Women with higher levels of education and higher income 
were found to use CAM at the greatest (NIH, 2017). Mind-body therapies include progressive 
muscle relaxation, meditation, hypnosis, guided imagery, yoga, and biofeedback. These 
approaches have been shown to be effective in reducing stress and anxiety, as well as chronic 
pain. However, levels of evidence vary (Hassed, 2013). The mind, emotions, and attention play 
an important role in patients experiencing chronic pain, stress, and fear (Hassed, 2013). The use 
of mind-body therapies can alleviate depression severity by improving one’s emotional state 
and mental health (Hassed, 2013). It helps patients focus their physical movement to train 
attention or produce mental relaxation (Hassed, 2013). A well-known and often popular mind-
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body therapy is yoga. Studies have found that yoga has improved mood and well-being by 
helping people master anxiety through self-care (Brown, Gerbarg, Philip, & Muskin, 2009). 
Gaps in Knowledge and Limitations of Previous Studies 
As the popularity of the use of mind-body therapies continues to grow, additional 
research is needed to determine the number of mind-body therapies necessary to see an effect 
on depressive symptoms. Previous studies have consistently reported that mind-body therapies 
help improve mental health. However, very few studies have specified how frequent mind-body 
therapies are used. Most studies analyzed the efficacy of mind-body modalities for stress 
reduction and pain reduction with a chronic condition. Moreover, existing reviews tend to focus 
their research on the prevalence use of CAM in a specific clinical population (Bishop, & Lewith, 
2010). This study assessed the association between the use of mind-body therapy and 
depressive symptoms, where the number of mind-body therapies one has ever practiced was 
considered in the analyses.  
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OBJECTIVE 
The objective of this study was to assess the association between the use of mind-body 
therapy and depressive symptoms. The analyses presented focus on determining whether 
mind-body therapy users are more or less likely to be depressed.  
Research Questions and Hypotheses 
Questions: 
1. Is there an association between the use of mind-body therapy and depressive 
symptoms? 
2. Is the frequency of the use of mind-body therapy associated with depressive symptoms? 
Hypotheses: 
1. There is a positive association between the use of mind-body therapy and depressive 
symptoms. 
2. There is a positive association between the frequency use of mind-body therapy and 
depressive symptoms 
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METHODS  
Data source 
 This study used the 2012 National Health Interview Survey (NHIS), a cross-sectional 
interview survey. The NHIS is part of the National Center for Health Statistics (NCHS), which is 
part of the Centers for Disease Control and Prevention (CDC). The NHIS is a source of 
information on the health of the noninstitutionalized population of the United States that 
began in 1957 as the result of the National Health Survey Act of 1956. It is an ongoing, 
nationwide, household interview survey about the overall health and health behaviors of a 
sampled population in the United States.  
The NHIS sampling plan consists of a multistage sampling, stratification and clustering of 
addresses located in the primary sampling units (PSU’s), which represents county and small 
neighboring counties, or a metropolitan statistical area. Individuals are randomly selected, and 
information is collected with the Sample Adult Core and the Sample Child Core questionnaire. 
Questionnaires consist of Core questions and Supplemental questions. Core questions 
addresses basic demographic information and health status on each household member. 
Supplemental questionnaire addresses new public health data such complementary and 
alternative medicine (CAM), Healthy People 2020, Children’s Mental Health, and Healthcare 
Utilization. NHIS has an oversampled population of Black, Hispanic, and Asian aged 65 or older, 
which means that they have a higher chance to be selected, so that these population groups 
are adequately representative as the population in the United States.  
 NHIS datasets are available to the public on the CDC website in ASCII format. These 
datasets are downloadable and output files available for use in several statistical software 
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packages. Sample syntax are also available for SAS, SPSS, and Stata. For this study, the Sample 
Adult file and the Adult Alternative Medicine file were used and analyses were conducted using 
SAS 9.4.  
NHIS is a secondary data and is a pre-approved public data source that did not require 
the Institutional Review Board (IRB) approval determined by Georgia State University IRB policy.  
Study Population  
 The study population of interest are adults in the United States who use mind-body 
therapies. 
Study Sample and Variables 
The study sample includes all participants in the Sample Adults and the Adult 
Complementary and Alternative Medicine datasets. The total study consisted of 34,525 
participants aged 18 years and older. Only individuals who responded to all questions regarding 
having depressive symptoms and using at least one mind-body therapy: “During the past 30 
days, how often did you feel so sad that nothing could cheer you up, nervous, restless or 
fidgety, hopeless, that everything was an effort, and worthless?” and “Have you EVER 
practice/use chiropractic or osteopathic manipulation, yoga, meditation (mantra meditation, 
mindfulness meditation, spiritual meditation), massage, guided imagery, progressive relaxation, 
tai chi, qi gong, acupuncture, biofeedback, hypnosis, or Alexander Technique?” were included 
in the analyses. The total eligible sample adults for the present analysis consisted of 11,143 
participants. Among the 11,143 participants, 62% reported moderate to high symptoms of 
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depression and 52% reported having none to low symptoms of depression while indicating the 
use of at least one mind-body therapy. 
Outcome of Interest 
 NHIS used the Kessler 6 (K6) screening scale, which is a standardized and validated 
measure of non-specific psychological distress, to assess depressive symptoms, the dependent 
variable in this study. K6 is composed of 6 questions asking, “During the past 30 days, how 
often did you feel so sad that nothing could cheer you up, nervous, restless or fidgety, hopeless, 
that everything was an effort, and worthless?” Responses were categorized as 0 (All of the 
time), 1 (Most off the time), 2 (Some of the time), 3 (A little of the time), 4 (None of the time). 
Individuals who answered “Refused” or “Don’t know” were excluded in the analyses. The scores 
were reversed in the study and were summed up to produce the outcome variable of interest. 
The lower the score indicates a better mental health. Scores ranges from 0 (No psychological 
distress) to 24 (Severe distress). The scores are classified into three distress groups: (0 - 12) 
none or low distress, (13 - 18) moderate distress, and (19 - 24) serious distress (Andrews & 
Slade, 2001; Kessler et al., 2010; Prochaska, Sung, Max, Shi, & Ong, 2012). Due to the lack of 
statistical power, depressive symptoms were also categorized as a dichotomous variable 
(Yes/No). Participants with a score lower than 7 were considered as not having psychological 
distress and higher than 7 as having psychological distress.  
Mind-Body Therapies 
The independent variable, the used of Mind-Body therapies, was determined using 
questions such as “Have you EVER practice/use chiropractic or osteopathic manipulation, yoga, 
meditation (mantra meditation, mindfulness meditation, spiritual meditation), massage, guided 
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imagery, progressive relaxation, tai chi, qi gong, acupuncture, biofeedback, hypnosis, or 
Alexander Technique?” Individuals who responded “Mentioned” were assumed to have used at 
least one type of mind-body therapy, and “Not Mentioned” as never used mind-body therapy. 
Responses were gathered and were classified by the number of mind and body therapies used 
(0, 1, 2, …, 10). All responses of “Refused”, “Not Ascertain”, and “Don’t Know” were excluded 
from the analysis due to small number of responses. Mind-Body modalities therapies such as 
Biofeedback, Hypnosis, Qi Gong, Alexander Technique, and Trager Psychophysical Integration 
were excluded from the binomial and multinomial logistic regression analyses due to small 
sample size. Three variables were created with these questions, a dichotomous variable 
(yes/no): whether an individual has practiced mind-body therapy; the number of mind-body 
therapies practiced per individual; and whether an individual practiced selected mind-body 
therapies. Selected mind-body therapies include yoga, meditation, chiropractic/osteopathic 
manipulation, and massage therapy. These therapies are the four most commonly used 
practices according to NHIS (NIH, 2017). Due to the lack of statistical power, only the four-
selected mind-body therapies were included in the logistic regression analysis and generalized 
linear mixed model analyses. The number of mind-body therapies practiced was considered as 
both a continuous and categorical variable. The number of mind-body modalities was not part 
of the NHIS survey questions, however, in the analyses, the number of mind-body modalities 
was combined into four categories. These four categories consist of zero, one, two, and more 
than three types of mind-body therapies used.  
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Sociodemographic Variables 
Sociodemographic variables were categorized as follows: gender (male, female), 
race/ethnicity (Non-Hispanic White, Non-Hispanic Black, Hispanic, Asian, Other/ Non-Hispanic 
Multiple race), and region was categorized as Northeast, Midwest, South, and West.  The value 
of age was considered as a continuous variable in its measured form. The sample size was 
exclusive to adults 18 years of age and above. The response of “Not Released” for race was 
excluded from the analyses due to small number of individuals who refused to release their 
race/ ethnicity.  
Chronic Conditions 
Chronic diseases such as Coronary Heart Disease, Stroke, Emphysema, Chronic 
Obstructive Pulmonary Disease (COPD), Asthma, Cancer, Diabetes, Arthritis, and BMI were 
included in the study as possible factors contributing to depressive symptoms. Question such as 
“Have you ever been told by a doctor or other health professional that you have Coronary 
Heart Disease, Stroke, Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Asthma, 
Cancer, Diabetes, or Arthritis” were asked to determine if an individual has certain chronic 
conditions. Responses such as “Yes” were considered in the analyses. All responses of 
“Refused”, “Not Ascertain”, and “Don’t Know” were excluded from the analyses. NHIS 
calculated BMI based on the height and weight variables using the equation: BMI= [Weight 
(kg)/ [Height (m) squared]] rounded to 2 decimal places. The value of BMI was considered as 
both continuous and categorical variable. BMI is categorized as underweight for a BMI below 
18.5, Normal for a BMI of 18.5 to 24.9, Overweight as 25.0 to 29.9, and Obese for 30.0 and 
above (Centers for Disease Control and Prevention, 2017). Due to the lack of statistical power, 
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emphysema was excluded from the logistic regression analysis and generalized linear mixed 
model analysis due to small sample sizes with some of the covariates used in these analyses. 
Physical and Strength Activities 
The frequency and duration of light/moderate activity and vigorous physical activity 
were assessed with questions “How often do you do LIGHT or MODERATE leisure-time physical 
activities for AT LEAST 10 MINUTES that cause ONLY LIGHT sweating or a SLIGHT to MODERATE 
increase in breathing or heart rate?” and “How often do you do VIGOROUS leisure-time 
physical activities for AT LEAST 10 MINUTES that cause HEAVY sweating or LARGE increases in 
breathing or heart rate?” According to the 2008 Physical Activity Guidelines (PAG) for 
Americans, adults should do at least 150 minutes a week of moderate- intensity (such as brisk 
walking or tennis), 75 minutes a week of vigorous intensity aerobic physical activity (such as 
jogging or swimming laps), or an equivalent combination of moderate-intensity and vigorous-
intensity aerobic physical activity (Office of Disease Prevention and Health Promotion, 2017).  
Light/Moderate and vigorous physical activity were combined and categorized into two levels: 
inactive and active. Adults who met the PAG guidelines of engaging in physical activity for at 
least 10 minutes per week were classified as “active,” and those who did not meet the criteria 
were classified as “inactive.” Strength activity was assessed with the question: “How often do 
you do physical activities specifically designed to STRENGTHEN your muscles such as lifting 
weights or doing calisthenics?” Weekly frequency was used to measure respondents’ level of 
physical and strength activities. Strength activity was also categorized into two levels: inactive 
and active. Adults who did muscle strengthening activities (such as lighting weights or using 
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resistance bands) for all major muscle groups on 2 or more days a week were classified as 
“active.” Adults who did not do any muscle strengthening activity were classified as “inactive.” 
Statistical Analyses 
 All analyses were conducted using the statistical software SAS 9.4. NHIS datasets 
responses were weighted accordingly based on the 2010 U.S. Census data to ensure that the 
sample was nationally representative.  
 Descriptive statistics were conducted to summarize the characteristics of the overall 
study sample. The weighted and unweighted frequencies for all demographics variables, 
covariates and depressive symptoms are summarized in Table 1 and Table 4. Table 1 includes 
the frequencies of individuals with depressive symptoms categorized by three levels: Low, 
Moderate, and High. Table 4 presents the frequencies of individuals with depressive symptoms 
as a dichotomous variable. PROC FREQ and PROC SURVEYFREQ were used to estimate the 
unweighted and weighted frequencies for depressive symptoms and each categorical variable. 
PROC MEANS and PROC SURVEYMEANS were used to produce the unweighted and weighted 
means for continuous variables (Age, BMI, and Number of mind-body therapies). Stratification, 
clustering, and sampling weight variables were utilized in PROC SURVEYFREQ and PROC 
SURVEYMEANS to indicate the structure of the data, and NOMCAR was specified to treat 
missing data as “not missing completely at random.”  
 Ordinal Logistic Regression was first performed to predict the probability of depressive 
symptoms given the use of mind-body therapies. In the ordinal logistic regression analysis, the 
three levels of depressive symptoms (No to Low depressive symptoms, Moderate depressive 
symptoms, and High depressive symptoms) were used. PROC LOGISTIC and PROC 
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SURVEYLOGISTIC with the default logit link were used to test the proportional odds assumption. 
The score test and p-value were observed in order to determine whether the proportional odds 
assumption was violated in the cumulative logistic regression model. If the assumption does 
not hold, the more general multinomial logistic regression model will be used.  
 Multinomial Logistic Regression was used to predict the probability of the categorical 
outcome of interest given the independent variables. Multinomial Logistic Regression used the 
three categories depressive symptoms variable (No to Low depressive symptoms, Moderate 
depressive symptoms, and High depressive symptoms). PROC LOGISTIC and PROC 
SURVEYLOGISTIC were used to produce the unadjusted and adjusted odds ratio, 95% 
confidence interval, and the p-value. The summary can be found in Tables 2 and 3. The STRATA, 
CLUSTER, and WEIGHT statement options were specified in the same manner as PROC 
SURVEYFREQ and PROC SURVEYMEANS. To fit the model using a generalized logit function, the 
LINK=GLOGIT option was specified in the MODEL statement.  
Due to estimation error in the generalized linear mixed model with the three levels of 
depressive symptoms, the outcome was categorized into a dichotomous variable. Depressive 
symptoms was categorized as No/Low depressive symptoms, and Moderate/High depressive 
symptoms. Binomial Logistic Regression was then used to predict the probability of the 
categorical outcome of interest given the independent variables. In order to run the binomial 
logistic regression analysis, PROC LOGISTIC and PROC SURVEYLOGISTIC were used to produce 
the unadjusted and adjusted odds ratio, 95% confidence interval, and the p-value. The 
summary can be found in Tables 5 and 6. The STRATA, CLUSTER, and WEIGHT statement 
options were specified in the same manner as PROC SURVEYFREQ and PROC SURVEYMEANS. To 
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fit the generalized logit models, the LINK=GLOGIT option was specified in the MODEL 
statement. 
 Generalized linear mixed models were used to predict the probability of depressive 
symptoms given the use of mind-body therapy while accounting for clustering of observations 
by region. PROC GLIMMIX was used to produce the unweighted unadjusted and adjusted odds 
ratio, 95% confidence interval, and the p-value. The WEIGHT statement was not used due to 
the nature of the data. Due to estimation error, the dichotomous variable of depressive 
symptoms was used in this model. A binomial distribution with a logit link function was 
specified. Region was specified as a random effect. The summary of the generalized linear 
mixed model analysis can be found in Table 7.  
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RESULTS 
Descriptive Statistics 
 Characteristics of the study sample are presented in Table 1 and 4. Table 1 presents 
individuals with depression symptoms, where depressive symptoms are categorized by three 
levels. Table 4 presents individuals with depressive symptoms, where depressive symptoms are 
categorized by two levels. All statistical interpretations observed use the weighted models, and 
the depressive symptoms categorized by two levels. Approximately 6% of this study sample 
reported having moderate and 2% reported having high depressive symptoms. Among these 
individuals, 50.79% were women and 49.21% were men. The mean age for those reported 
having experienced depressive symptoms was 38.38 years of age. Most of the study sample 
who reported moderate/high depressive symptoms was non-Hispanic White (68.78%) 
compared to Hispanic (14.20%), non-Hispanic Black (9.62%), non-Hispanic Asian (2.71%), and 
other race (4.68%). Individuals the South region of the United States (33.05%) were more likely 
to be depressed compared to West (28.51%), Midwest (23.18%), and Northeast (15.26%). A 
map of the U.S. with NHIS grouping of regions can be seen in Figure 1. Among all chronic 
conditions (arthritis, asthma, diabetes, cancer, CHD, COPD, stroke, emphysema, and BMI 
classification) explored in this analysis, individuals with arthritis, asthma, and 
overweight/obesity had the highest prevalence of depressive symptoms with 21.54%, 20.38%, 
31.47%, and 32.37% respectively. When asked if individuals with moderate/high depressive 
symptoms had practiced at least one of the mind-body therapies (yoga, 
chiropractic/osteopathic manipulation, massage, meditation, Pilates, acupuncture, tai chi, 
progressive relaxation, guided imagery, hypnosis, qi gong, biofeedback, alexander technique, or 
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Trager psychophysical integration), 62.18% responded “Yes” and 37.82% responded “No.” 
Among those who reported moderate/high depressive symptoms, 37.78% reported never used 
any type of mind-body modalities, 24.11% reported using one type of mind-body modalities, 
11.87% reported using two types of mind-body modalities, and 26.23% reported using more 
than 3 types of mind-body modalities. Out of the most commonly practiced mind-body 
therapies (yoga, meditation, massage, and chiropractic/osteopathic manipulation), 58.97% of 
respondents reported moderate/high depressive symptoms compared to 48.69% who reported 
no/low depressive symptoms. For physical and strength activities, 87.92% reported having 
moderate/high depressive symptoms compared to 92.39% who reported no/low depressive 
symptoms when exercising for at least 150 minutes a week of moderate-intensity activities or 
75 minutes a week of vigorous-intensity aerobic physical activities. Among individuals who 
reported moderate/high depressive symptoms, 36.96% reported engaging actively in weight 
training at least once a week compared to 63.04% of individuals who did not report engaging in 
weight training.  
Ordinal Logistic Regression 
 Ordinal logistic regression analysis was performed to examine how the variable of 
interest and the covariates were associated with depressive symptoms. The score test and       
p-value were observed to assess the proportional odds assumption test. Results showed a 
significant p-value for all variables. For example, age had a chi-square value of 8.38 and a p-
value of 0.0038, and the use of at least one mind-body therapy had a chi-square value of 13.09 
with a p-value of 0.0003. These results showed a violation of the proportional odds assumption 
test, therefore, a multinomial logistic regression model was best used. 
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Multinomial Logistic Regression 
 Multinomial logistic regression analyses were conducted to examine how the variable of 
interest and the covariates were associated with depressive symptoms. Tables 2 and 3 present 
odds ratio, 95% confidence interval (95% CI), and p-value for demographic characteristics, 
physical and strength activities, and mind-body modalities among those who have reported 
experiencing no/low depressive symptoms, moderate depressive symptoms, and high 
depressive symptoms.  
 In the weighted unadjusted multinomial logistic regression model, for each additional 
year of age, the odds of having moderate or high depressive symptoms as compared to a none/ 
low level of depressive symptoms was close to 1 [OR= 0.99, 95% CI (0.98, 1.00)]. The results 
were similar for BMI [high vs low: OR= 1.01, 95% CI (1.00, 1.02)], [moderate vs low: OR= 1.01, 
95% CI (1.00, 1.02)]. Females were more likely to have moderate vs low [OR= 1.04, 95% CI 
(0.85, 1.28)] or high vs low [OR=1.68, 95% CI (1.19, 2.39)] depressive symptoms than males. 
Hispanic participants were more likely to have moderate vs low [OR= 1.13, 95% CI (0.84, 1.52) 
or high vs low [OR= 1.69, 95% CI (1.08, 2.65)] depressive symptoms compared to Non-Hispanic 
Whites. Non-Hispanic Black participants were equally likely to have moderate depressive 
symptoms as compared to low depressive symptoms [OR= 0.97, 95% CI (0.71, 1.34)], but had 
increased odds for high vs low depressive symptoms [OR= 1.44, 95% CI (0.85, 2.42)]. Non-
Hispanic Asians were less likely to have moderate vs low [OR=0.63, 95% CI (0.42, 0.93)] or high 
vs low [OR=0.33, 95% CI 0.10, 1.10)] depressive symptoms as compared to non-Hispanic 
Whites. Arthritis, asthma, diabetes, COPD, and BMI classification were statistically significantly 
associated with depressive symptoms in this multinomial logistic regression model. Participants 
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with arthritis had increased odds for both moderate vs low [OR=1.37, 95% CI (1.09, 1.73)] and 
high vs low [OR=2.38, 95% CI (1.59, 3.55)] depressive symptoms. Similarly, for participants with 
asthma, participants had increased odds for moderate vs low [OR=1.93, 95% (1.50, 2.49)] and 
high vs low [OR= 2.21, 95% CI (1.46, 3.34)] depressive symptoms. Participants with diabetes and 
stroke also showed increased odds for moderate vs low and high vs low depressive symptoms. 
Diabetic participants were more likely to have moderate vs low depressive symptoms [OR= 
1.61, 95% CI (1.09, 2.40)] and high vs low depressive symptoms [OR= 1.99, 95% CI (1.19, 3.34)] 
as compared to non-Diabetic participants. Participants diagnosed with COPD were more likely 
to have moderate vs low [OR=1.60, 95% CI (0.90, 4.26)] or high vs low [OR= 7.94, 95% CI (3.61, 
17.46)] depressive symptoms than those who had never been diagnosed with COPD. Those who 
reported using at least one mind-body therapy were more likely to experience moderate vs low 
depressive symptoms [OR= 1.60, 95% CI (1.30, 1.98)] and high vs low depressive symptoms 
[OR= 1.19, 95% CI (0.86, 1.64)]. Participants who reported using the most common mind-body 
therapies (yoga, meditation, acupuncture, and chiropractic/ osteopathic manipulation) also 
showed an increased odd for moderate vs low [OR= 1.57, 95% CI (1.27, 1.93)] and high vs low 
[OR= 1.33, 95% CI (0.97, 1.83)] depressive symptoms. Individuals who reported using multiple 
mind-body therapies were more likely to experience moderate vs low [OR= 1.13, 95% CI (1.08, 
1.17) or high vs low [OR= 1.14, 95% CI (1.07, 1.22)] depressive symptoms. Individuals who 
reported physical activity and strength activity were less likely to have moderate vs low 
depressive symptoms [OR=0.62, 95% CI=0.42, 0.92] and were less likely to have high vs low 
[OR=0.52, 95% CI= 0.30, 0.90] depressive symptoms, and individuals who reported weight 
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lifting were similarly less likely to have both moderate vs low [OR= 0.78, 95% CI= 0.65, 0.95] and 
high vs low [OR= 0.56, 95% CI (0.38, 0.81)].  
 In the weighted adjusted multinomial logistic regression model, age [moderate vs low 
depressive symptoms: OR= 0.97, 95% CI (0.97, 0.98); high vs low depressive symptoms: OR= 
0.97, 95% CI (0.97, 0.98)], race [moderate vs low depressive symptoms: Hispanic: OR= 1.13, 
95% CI (0.82, 1.56), NH-Black: OR= 0.93, 95% CI (0.66, 1.31), NH-Asian: OR= 0.73, 95% CI (0.49, 
1.09); high vs low depressive symptoms: Hispanic: OR= 1.68, 95% CI (1.05, 2.70), NH-Black: OR= 
1.34, 95% CI (0.77, 2.36), NH-Asian: OR= 0.36, 95% CI (0.11, 1.19)], arthritis [moderate vs low 
depressive symptoms: OR= 1.49, 95% CI (1.14, 1.96); high vs low depressive symptoms: OR= 
2.96, 95% CI (1.76, 4.92)], asthma [moderate vs low depressive symptoms: OR= 1.56, 95% CI 
(1.20, 2.02); high vs low depressive symptoms: OR= 1.49, 95% CI (0.96, 2.31)], diabetes 
[moderate vs low depressive symptoms: OR= 1.78, 95% CI (1.15, 2.76); high vs low depressive 
symptoms: OR= 1.87, 95% CI (1.04, 3.37)], COPD [moderate vs low depressive symptoms: OR= 
1.72, 95% CI (0.74, 4.04); high vs low depressive symptoms: OR= 7.05, 95% CI (2.95, 16.97)], the 
use of at least one mind-body therapy [moderate vs low depressive symptoms: OR=1.41, 95% 
CI (0.85, 2.33); high vs low depressive symptoms: OR= 0.21, 95% CI (0.06, 0.77)], number of 
mind-body therapies used [moderate vs low depressive symptoms: OR= 1.11, 95% CI (1.05, 
1.18); high vs low depressive symptoms: OR= 1.14, 95% CI (1.05, 1.24)], and strength activity 
[moderate vs low depressive symptoms: OR= 0.75, 95% CI (0.62, 0.91); high vs low depressive 
symptoms: OR= 0.56, 95% CI (0.37, 0.83)] remained statistically significant with the association 
of moderate or high vs low depressive symptoms when controlling for all other variables. BMI, 
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physical activity, and selected mind-body therapies became statistically insignificant when 
controlling for all other variables in this model.  
Binomial Logistic Regression 
 Binomial logistic regression analyses were conducted to examine how the variable of 
interest and the covariates were associated with depressive symptoms as a dichotomous 
variable. Tables 5 and 6 present odds ratios, 95% confidence interval (95% CI), and p-values for 
demographic characteristics, physical and strength activities, and mind-body modalities among 
those who have reported experiencing no/low depressive symptoms and moderate/high 
depressive symptoms.  
 In the weighted unadjusted binomial logistic model, age and race were demographic 
characteristics that yielded a statistically significant association with depressive symptoms. For 
each additional year of age, the odds of being depressed had a 0.99 decrease in odds [OR= 0.99, 
95% CI (0.98, 0.99)]. Hispanic [OR= 1.23, 95% CI (0.96, 1.58)] and non-Hispanic Blacks [OR= 1.06, 
95% CI (0.79, 1.42)] had increased odds of experiencing depressive symptoms as compared to 
non-Hispanic Whites. Non-Hispanic Asians [OR= 0.58, 95% CI (0.39, 0.85)] had decreased odds 
of experiencing depressive symptoms. Sex [OR= 1.14, 95% CI (0.95, 1.37)] and region [South: 
OR=0.88, 95% CI (0.70, 1.10); Midwest: OR= 0.87, 95% CI (0.67, 1.13); Northeast: OR= 0.89, 95% 
CI (0.69, 1.16)] did not yield statistically significant associations with depressive symptoms. 
Most chronic conditions including arthritis [OR= 1.55, 95% CI (1.27, 1.89)], asthma [OR=1.98, 
95% CI (1.59, 2.48)], diabetes [OR=1.69, 95% CI (1.22, 2.34)], and COPD [OR=3.09, 95% CI (1.76, 
5.410)] yielded statistically significant associations with depressive symptoms. Other chronic 
conditions such as cancer [OR= 1.19, 95% CI (0.88, 1.62)], CHD [OR=1.36, 95% CI (0.79, 2.32)], 
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and stroke [OR=1.39, 95% CI (0.82, 2.35)] did not yield statistically significant associations with 
depressive symptoms. Underweight as compared to normal weight participants were more 
likely to be depressed [1.58, 95% CI (0.69, 3.62)] and overweight vs normal weight participants 
were slightly more likely to be depressed [OR=1.05, 95% CI (0.83, 1.33)]. Obese as compared to 
normal weight individuals were more likely to be depressed [OR= 1.52, 95% CI (1.19, 1.94)]. 
Both physical activities [OR= 0.60, 95% CI (0.43, 0.84)] and strength activities [OR= 0.73, 95% CI 
(0.62, 0.87)] were negatively associated with depression. The use of at least one mind-body 
therapy [OR= 1.51, 95% CI (1.26, 1.81)], the use of selected mind-body therapies [OR=1.51, 95% 
CI (1.27, 1.81)], and the number of mind-body therapies used [OR=1.13, 95% CI (1.09, 1.17)] all 
yielded statistically significant association with depressive symptoms. The odds of being 
depressed increased with the use of mind-body therapies. This could also be interpreted as 
depressed individuals were more likely to be using mind-body therapies. This interpretation 
aligned with findings in some studies in the literature. 
 When comparing the unweighted and weighted unadjusted binomial logistic regression 
results, sex was found to be statistically significant in the unweighted model [OR= 1.24, 95% CI 
(1.09, 1.43)] but became statistically insignificant when accounting for sampling weights [OR= 
1.14, 95% CI (0.95, 1.37)]. When region was included as a fixed effect, region [South: OR= 0.82, 
95% CI (0.70, 0.97), Midwest: OR= 0.76, 95% CI (0.62, 0.92), Northeast (OR= 0.87, 95% CI (0.70, 
1.07)] was also statistically significant in the unweighted model but statistically insignificant in 
the weighted model.  
In the weighted adjusted logistic model, sex [OR=0.99, 95% CI (0.81, 1.21)], region 
[South: OR=0.94, 95% CI (0.75, 1.17); Midwest: OR= 0.87, 95% CI (0.67, 1.12), and Northeast: 
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OR= 0.95, 95% CI (0.71, 1.27)], BMI [OR= 1.01, 95% CI (1.00, 1.01)], CHD [OR= 1.54, 95% CI 
(0.85, 2.79)], stroke [OR= 1.03, 95% CI (0.56, 1.92)], the use of at least one mind-body therapy 
[OR= 1.12, 95% CI (0.69, 1.83)], and most common used mind-body therapies [OR= 1.09, 95% CI 
(0.69, 1.75)] all failed to reach statistically significant level associations with depressive 
symptoms while controlling for all other variables in this model. Age [OR= 0.97, 95% CI (0.96, 
0.98)], race [Hispanic: OR= 1.23, 95% CI (0.94, 1.61), non-Hispanic Black: OR= 1.01, 95% CI 0.74, 
1.38), non-Hispanic Asian: OR= 0.66, 95% CI (0.44, 0.97, and non-Hispanic Other: OR= 1.88, 95% 
CI (1.12, 3.18)], arthritis [OR= 1.72, 95% CI (1.36, 2.17)], asthma [OR= 1.55, 95% CI (1.23, 1.95)], 
diabetes [OR= 1.81, 95% CI (1.26, 2.59)], the number of mind-body therapies used [OR= 1.12, 
95% CI (0.69, 1.83)], physical activity [OR= 0.67, 95% CI (0.47, 0.95)], and strength activity [OR= 
0.71, 95% CI (0.60, 0.84)] remained significantly associated with depressive symptoms when 
controlling for all other variables in this model. Cancer [OR= 1.23, 95% CI (1.02, 2.01)] and COPD 
[OR= 2.70, 95% CI (1.45, 5.03)] were found statistically significant when controlling for all other 
variables compared to the unadjusted logistic regression model.  
Generalized Linear Mixed Model 
 Generalized Linear Mixed Model results account for clustering by region are presented 
in Table 7. In the unadjusted multilevel modeling model, for each additional year of age, the 
odds of having depressive symptoms decreased by 0.97 [OR= 0.97, 95% CI (0.97, 0.98)]. 
Hispanics [OR= 1.26, 95% CI (1.03, 1.55)] had higher odds of having depressive symptoms, while 
non-Hispanic Blacks [OR= 0.18, 95% CI (0.95, 1.47)] and non-Hispanic Asians [OR= 0.82, 95% CI 
(0.57, 1.18)] were less likely to have depressive symptoms. Similarly, to binomial and 
multinomial logistic regression models, arthritis [OR= 1.80, 95% CI (1.49, 2.18)], asthma [OR= 
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1.65, 95% CI (1.38, 1.97)], diabetes [OR= 1.82, 95% CI (1.39, 2.38), COPD [OR= 2.38, 95% CI 
(1.48, 3.82)], and stroke [OR= 1.87, 95% CI (1.14, 3.07)] were statistically significantly associated 
with depressive symptoms. Cancer [OR=1.47, 95% (1.13, 1.92)] was found to be statistically 
significant in this model. Physical activity and strength activity had 0.76 and 0.73, respectively, 
the odd of being more likely to have depressive symptoms. Weight categorization results were 
similar, with slightly different odds ratio point estimates. As for mind-body modalities, only the 
number of mind-body therapies used was found to be statistically significant with a negative 
association with depressive symptoms. 
 In the adjusted multilevel model, sex [OR= 1.08, 95% CI (0.93, 1.25)], BMI [OR= 1.00, 
95% CI (0.99, 1.01)], CHD [OR= 1.37, 95% CI (0.88, 2.13)], the used of at least one mind-body 
therapy [OR= 1.04, 95% CI (0.70, 1.55)], and selected mind-body therapies [OR= 1.07, 95% CI 
(0.72, 1.59)] all failed to yield statistically significant with depressive symptoms. All other 
variables: age [OR=0.97, 95% CI (0.97, 0.980; race: Hispanic [OR= 1.26, 95% CI (1.03, 1.55)], NH- 
Black [OR= 0.18, 95% CI (1.18, 95% CI (0.95, 1.47)], NH- Asian [OR=0.82, 95% CI (0.57, 1.18), NH- 
Other [OR= 1.60, 95% CI (1.13, 2.27)]; arthritis [OR= 1.80, 95% CI (1.49, 2.18)]; asthma [OR= 
1.65, 95 CI (1.38, 1.97)]; diabetes [OR= 1.82, 95% CI (1.39, 2.38)]; cancer [OR= 1.47, 95% CI 
(1.13, 1.92)]; CHD [OR=1.37, 95% CI (0.88, 2.130); COPD [OR= 2.38, 95% CI (1.48, 3.82)], BMI 
Classification: underweight [OR= 1.11, 95% CI (0.61, 2.01)], overweight [OR= 1.16, 95% CI (0.97, 
1.39)], obese [OR= 1.45, 95% CI (1.16, 1.80)]; number of mind-body therapies used [OR= 1.12, 
95% CI (1.07, 1.16)]; physical activity [OR= 0.75, 95% CI (0.60, 0.94)]; and strength activity [OR= 
0.69, 95% CI (0.60, 0.80)], yielded statistical significance when controlling for all other variables. 
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Multilevel modeling with clustering observation by region added a layer of complexity 
that was likely adding to the complexity of the modeling process, with marginal added benefit.  
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DISCUSSION 
 The aim of this study was to investigate the association between the use of mind-body 
therapies and depressive symptoms. The results from this analysis are consistent with previous 
finding. Results of this study showed a negative association between the use of mind-body 
therapy and mental health. Results in the analyses were quite contradictory, where in the 
unadjusted multinomial logistic regression, the use of at least one mind-body therapy, the 
number of mind-body therapies used, and the most common used mind-body therapies all 
yielded statistically significant association with depressive symptoms, but in the adjusted 
multinomial logistic regression, the most common used mind-body therapies were not 
associated with depressive symptoms. Moreover, the binomial logistic regression analyses 
show the same pattern, where in the unadjusted binomial logistic regression, the use of at least 
one mind-body therapy, the number of mind-body therapies used, and the most common used 
mind-body therapies all yielded statistically significant association with depressive symptoms. 
However, in the adjusted binomial logistic regression, only the number of mind-body therapies 
used remained statistically significant. This contradiction makes the interpretation of the results 
difficult. All unadjusted models indicate that there were a statistically significant association 
between the association of the use of mind-body therapy and depressive symptoms, but 
become statistically insignificant when controlling for all other variables. This means that there 
is an effect modifier, where different groups of individuals (e.g., region) may affect depressive 
symptoms differently. For example, people living in the West of the United States are often 
found to be less depressed than people living in the South of the United States (CDC, 2010).  
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When only observing the statistically significant association between the use of mind-
body therapy and depressive symptoms, results suggest that individuals who use mind-body 
therapies are more likely to be depressed individuals. These results support the research 
literature, where depressed individuals are more likely to seek out additional treatment to 
reduce stress or to find a cure (Bishop, & Lewith, 2010). In the context of CAM usage, 
individuals who suffer from chronic conditions or have a life-threatening disease were more 
likely to use mind-body modalities (Bishop, & Lewith, 2010). Moreover, individuals who are not 
satisfied by conventional medicine and who are experiencing psychological distress were also 
more likely to turn to CAM modalities (Lee-Treweek, 2005). Mind-body therapies have shown 
to be beneficial for the improvement of mental health. Although this study does not allow for 
assessing the causal relationship of mind-body therapies and depressive symptoms due to the 
nature of the data, an experimental study may be beneficial to assess the causal relationship 
between mind-body therapies and depressive symptoms.  
The logistic regression analyses results reflect and correspond to epidemiological data 
about chronic conditions and depressive symptoms. The findings support research literature 
that arthritis, asthma, diabetes, cancer, and COPD affect individuals’ mental health and well-
being. Many studies evaluate the use of CAM modalities due to chronic conditions. Studies 
have found that the use of CAM modalities increased with a higher numbers of chronic health 
conditions (Bishop, & Lewith, 2010). An UK-based study analyzed CAM use with arthritis, 
cancer, and diabetes (Bishop, & Lewith, 2010). In their bivariate tests, 53% of individuals with 
arthritis, 30% of individuals with cancer, and 24% of individuals with diabetes were found to be 
using CAM modalities due to having anxiety or depression (Bishop, & Lewith, 2010). In this 
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analysis, the association between chronic conditions and the use of mind-body therapies was 
not assessed but it was found that mind-body therapies users were more likely to be depressed 
individuals. Thus, the assumption that individuals with comorbid chronic conditions and 
depression were also more likely to use mind-body modalities. It was found that individuals 
with diabetes (7.65%), cancer (7.39%), CHD (3.09%), COPD (2.77%), stroke (1.46%), and 
emphysema (1.63%) were less likely to report depressive symptoms compared to arthritis 
(21.54%) and asthma (20.38%). In the analyses, COPD was found to have a large confidence 
interval, this may be due to small sample size of individuals reported having COPD while 
indicating the use of at least one mind-body therapy. In all the analyses conducted, BMI 
classification showed a U-shape relationship, where individuals who were underweight or 
obese were more likely to experience moderate to high depressive symptoms. This finding 
supports the literature reviews that many factors can contribute to or be related to depressive 
symptoms. Many studies have found this U-shape relationship between depression and BMI. 
The Diagnostic and Statistical Manual of Mental Disorder (DSM-IV) defined depression with an 
association with both an increased and decreased intake of food, or an increased and 
decreased of physical activity (American Psychiatric Association, 2013). According to DSM-IV’s 
definition of association between BMI and depression, it seems logical to state that increased 
levels of depression is associated with either obesity or underweight. In this analysis, 
comorbidity of chronic conditions, physical and strength activities were considered, however, 
other factors such as socioeconomic level and education level were not included in this study. 
Unfortunately, it was not possible to include all possible confounding variables to assess the 
relationship with depressive symptoms.  
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Findings regarding physical activity and strength activity support research literature that 
physical activity and strength activity can improve mental health. One study conducted with the 
adult population in Brazil indicated that people who do not engage in physical activity were two 
times more likely to exhibit symptoms of depression and anxiety compared to those who 
exercise regularly (De Mello, Lemos, Antunes, Bittencourt, Santos-Silva, & Tufik, 2013). 
Additional studies exploring whether adults with major depression and who are physically 
active differ in their depression symptoms profile also found that physically active individuals 
were less likely to endorse suicidality compare to those who are physically inactive (McKercher, 
Patton, Schmidt, Venn, Dwyer, & Sanderson, 2013). Individuals who are actively exercising, 
even light intensity physical activity, whether it is aerobic physical activity or strength training, 
was found to have positive mental health effects (Loprinzi, 2013). In this analysis, similar results 
were found, where individuals who are physically active were less likely to experience 
depressive symptoms. However, there were no descriptions of the types of exercise practiced, 
and physical and strength activities were only classified as active or inactive according to CDC’s 
recommendation of exercise. 
Limitations 
Several limitations of this study were due to the design of NHIS survey data. First, the 
NHIS is cross-sectional data, where only the association between the use of mind-body 
therapies and depressive symptoms could be examined. The causal relationship of these 
measures cannot be determined so we were unable to assess whether the use of mind-body 
therapies increases depressive symptoms, or whether individuals with depressive symptoms 
are more likely to use mind-body therapies. The NHIS survey is based on self-reported 
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responses, which are subjected to recall bias. The sample size of this study could not include all 
the participants in NHIS due to missing data. Only those who responded to both questions 
regarding depressive symptoms and the use of mind-body therapies were included in the 
analyses. This is important for the analyses because the calculation of sample size makes use of 
the expected proportion with the specified outcome of interest. Individuals who did not 
respond to both questions would not be relevant in the study, and would not give a precise and 
accurate conclusion. Moreover, the question “Have you EVER practice/use chiropractic or 
osteopathic manipulation, yoga, meditation (mantra meditation, mindfulness meditation, 
spiritual meditation), massage, guided imagery, progressive relaxation, tai chi, qi gong, 
acupuncture, biofeedback, hypnosis, or Alexander Technique?” may not accurately portray 
whether individuals have recently practiced mind-body therapies, or practiced mind-body 
therapies a few years back. Also, there was no indication of the frequency or the duration of 
mind-body therapies practiced. This type of information is important for future studies when 
examining whether mind-body therapies do improve mental health.  
An additional limitation is that the ordinal nature of the outcome was lost when the 
multinomial logistic regression analysis was conducted in place of ordinal logistic regression 
with depressive symptoms as the response variable. Because the ordinal nature was not used in 
the analysis, this added layer of information about the outcome was not accounted for in the 
analyses. Missing values were also a limitation, especially for mind-body therapies. All 
participants were given the questions about the alternative supplement, however, those who 
did not complete the supplement were given the value of “Not Ascertain,” or some answers 
were missing.  
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Future Studies  
As the complementary and alternative supplement survey questions are assessed every 
five years, new data on mind-body therapies should be available soon and may have additional 
questions to clarify the use of mind-body therapy. For example, giving an actual time frame to 
the use of mind-body therapies may improve the accuracy of the measurement of the use of 
mind-body therapies. Although, the question “Have you practiced (a type of mind-body 
therapy) in the past 12 months” was available from the survey data, the respondents were 
limited to those who had responded “yes” to the question “Have you EVER practiced (a type of 
mind-body therapy), which created an extensive number of missing values. Although this study 
used a cross-sectional data, where all responses were self-reported, there were no details of 
the intention of practicing mind-body therapies. It is not clear why participants practiced mind-
body treatments. Thus, it was not possible in the present study to determine whether 
respondents were using these therapies specifically as a treatment for their mental health 
issues, for other health problems or for reasons unrelated to health problems. A pilot 
qualitative study may be beneficial to understand better the health behavior relevant to 
participating in a type of mind-body therapy. 
Conclusion 
 A negative association was found between the use of mind-body therapy and depressive 
symptoms among U.S. adults in all unadjusted models. When controlling for all covariates, 
certain variables regarding the use of mind-body therapy became statistically insignificant with 
the association of depressive symptoms. The negative association results support findings 
reported in previous studies that mind-body therapies users are more likely to be depressed 
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individuals. Findings suggest that people with at least one chronic condition were more likely to 
seek out additional treatment, other than the conventional medicine, and that promoting 
physical activity and strength activity may help improve mental health. Although the 
methodology in the present study does not allow assigning a relation of cause and effect, the 
association between mind-body modalities and depressive symptoms was observed.  
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FIGURES AND TABLES 
Figure 1:  Map of the U.S. with NHIS- Defined Regions
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Table 1: Frequency of Individuals with Depressive Symptoms (Three Levels of Depression Symptoms) by Sample Characteristics, 2012 
National Health Interview Survey (NHIS) (N=11,143) 
 Depressive Symptoms    
 Low (N= 10232) Moderate (N= 705) High (N= 206)    
Variables Unweighted 
Count 
Unweighted 
(%) 
Weighted 
(%) 
Unweighted 
Count 
Unweighted 
(%) 
Weighted 
(%) 
Unweighted 
Count 
Unweighted 
(%) 
Weighted 
(%) 
Total Total 
Unweighted 
(%) 
Total 
Weighted 
(%) 
Age in years Mean (SD) 10232 42.78 (16.07) 41.96 705 39.77 (14.76) 38.33 206 39.56 (13.62) 38.59 11143 42.53 (15.97) 41.70 
BMI (Mean SD) 10232 28.43 (11.57) 28.34 705 29.82 (12.18) 30.21 206 29.75 (12.49) 29.37 11143 28.54 (11.64) 28.46 
Sex             
Female 5162 50.45 47.47 384 54.47 48.44 125 60.68 60.35 5671 50.89 47.71 
Male 5070 49.55 52.53 321 45.53 51.56 81 39.32 39.65 5472 49.11 52.29 
Race             
NH- White 6775 66.21 71.71 449 63.69 70.52 115 55.83 62.75 7339 65.86 71.50 
Hispanic 1389 13.58 12.05 101 14.33 13.39 45 21.84 17.80 1535 13.78 12.21 
NH- Black 1235 12.07 9.47 95 13.48 9.07 29 14.08 11.91 1359 12.20 9.48 
NH- Asian 577 5.64 4.67 32 4.54 2.88 3 1.46 1.35 612 5.49 4.52 
NH- Other 256 2.50 2.09 28 3.97 4.15 14 6.80 6.18 298 2.67 2.28 
Region             
South 3500 34.21 34.23 234 33.19 33.75 62 30.10 30.38 3796 34.07 34.14 
West 2943 28.76 25.72 222 31.49 26.65 81 39.32 35.15 3246 29.13 25.93 
Midwest 2239 21.88 24.43 139 19.72 24.10 35 16.99 19.86 2413 21.65 24.34 
Northeast 1550 15.15 15.63 110 15.60 15.50 28 13.59 14.61 1688 15.15 15.60 
Chronic Conditions             
Arthritis 1629 15.92 15.11 159 22.55 19.64 60 29.13 29.72 1848 16.58 15.58 
Asthma 1200 11.77 11.39 155 21.90 19.88 44 21.36 22.07 1399 12.55 12.05 
Cancer 654 6.39 6.29 61 8.65 7.40 17 8.25 7.46 732 6.57 6.37 
Diabetes 529 5.17 4.71 60 8.51 7.34 23 11.17 8.91 612 5.49 4.92 
CHD  235 2.30 2.28 21 2.98 2.95 7 3.40 3.54 263 2.36 2.34 
COPD 107 1.05 0.92 16 2.27 1.78 12 5.83 6.84 135 1.21 1.06 
Stroke 112 1.09 1.061 14 1.99 1.15 8 3.88 2.71 134 1.20 1.09 
Emphysema 65 0.64 0.62 8 1.13 1.18 8 3.88 3.49 81 0.73 0.70 
BMI Classification             
Underweight 123 1.20 1.50 10 1.42 2.15 3 1.46 1.67 136 1.22 1.54 
Overweight 3547 34.67 34.57 238 33.76 32.76 55 26.70 26.07 3840 34.46 34.34 
Obese 2537 24.79 24.63 229 32.48 32.63 70 33.98 31.78 2836 25.45 25.20 
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Normal 4025 39.34 39.29 228 32.34 32.46 78 37.86 40.47 4331 38.87 38.91 
The Use of at least one 
Mind-Body Therapy 
            
Yes 5390 52.68 52.13 441 62.55 63.62 116 56.31 56.47 5947 53.37 52.87 
No 4842 47.32 47.87 116 56.31 36.38 90 43.69 43.53 5196 46.63 47.13 
Mind- Body Therapies             
Chiropractic/ 
Osteopathic  
3068 29.98 29.79 261 37.02 36.24 77 37.38 38.64 3406 30.57 30.29 
Yoga 2344 22.91 22.89 181 25.67 26.34 49 23.79 22.28 2574 23.10 23.09 
Massage 2234 21.83 21.23 211 29.93 27.72 58 28.16 31.14 2503 22.46 21.76 
Spiritual 
Meditation * 
534 50.71 51.67 75 51.72 49.38 21 48.84 52,42 630 50.77 51.43 
Mindfulness 
Meditation * 
427 40.55 40.27 56 38.62 35.35 18 41.86 32.37 501 40.37 39.46 
Mantra Meditation 
* 
401 38.08 38.08 61 42.07 35.42 25 58.14 57.54 487 39.24 38.25 
Pilates 1201 11.74 11.39 93 13.19 14.90 26 12.62 14.08 1320 11.85 11.64 
Acupuncture 808 7.90 7.54 63 8.94 7.88 20 9.71 11.72 891 8.00 7.62 
Tai Chi 517 5.05 4.67 47 6.67 5.80 13 6.31 5.56 577 5.18 4.75 
Progressive 
Relaxation * 
463 43.97 43.96 71 48.97 49.47 24 55.81 51.20 558 44.96 44.82 
Guided Imagery * 418 39.70 40.61 60 41.38 41.18 21 48.84 46.20 499 40.21 40.83 
Hypnosis 176 1.72 1.58 27 3.83 3.46 13 6.31 6.48 216 1.94 1.76 
Qi Gong 140 1.37 1.10 10 1.42 1.35 3 1.46 1.32 153 1.37 1.11 
Biofeedback 127 1.24 1.23 22 3.12 2.71 10 4.85 4.33 159 1.43 1.36 
Alexander 
Technique 
56 0.55 0.52 6 0.85 0.88 1 0.49 0.04 63 0.57 0.54 
Trager 
Psychophysical 
Integration 
22 0.22 
 
0.17 3 0.43 0.32 1 0.49 0.37 26 0.23 0.18 
Number of Mind Body 
Therapies Used 
            
0 4853 47.35 47.85 264 37.45 36.38 90 43.69 43.53 5209 46.65 47.11 
1 2376 23.18 23.49 168 23.83 26.11 36 17.48 15.93 2580 23.11 23.54 
2 1330 12.98 12.60 90 12.77 11.57 24 11.65 13.10 1445 12.94 12.55 
3+ 1691 16.50 16.06 183 25.96 25.94 56 27.18 27.44 1931 17.30 16.81 
Most common used Mind 
Body Therapies (Yoga, 
Meditation, Massage, and 
Chiropractic/Osteopathic) 
 
5020 
 
48.98 
 
48.69 
 
414 
 
58.72 
  
113 
 
54.85 
  
5549 
 
49.70 
 
49.45 
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Physical Activity             
Active  9482 92.51 92.39 629 89.22 88.30 181 87.86 86.39 10295 92.21 92.06 
Inactive  768 7.49 7.611 76 10.78 11.70 25 12.14 13.61 870 7.79 7.94 
Strength Activity             
Active 4454 43.45 44.40 257 36.45 38.46 62 30.10 30.81 4776 42.78 43.86 
Inactive  5796 56.55 55.60 448 63.55 61.54 144 69.90 69.19 6389 57.22 56.14 
* Survey Questions for meditations and guided imagery had missing value 
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Table 2: Unadjusted Multinomial Logistic Regression of Depressive Symptoms and the Use of Mind-Body Therapies, 2012 National 
Health Interview Survey (NHIS) 
 Unweighted Unadjusted Odds Ratio (OR) 
 
Weighted Unadjusted Odds Ratio (OR) 
 Moderate vs. Low 
Depressive Symptoms 
High vs. Low 
Depressive Symptoms 
 Moderate vs. Low 
Depressive Symptoms 
High vs. Low 
Depressive Symptoms 
 
Variables Odds 
Ratio 
95% 
Confidence 
Interval 
Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC Odds 
Ratio 
95% 
Confidence 
Interval 
Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC 
Age in years  0.99 0.98, 0.99 0.99 0.98, 1.00 < 0.0001 7258.169 0.99 0.98, 0.99 0.99 0.98, 1.00 < 0.0001 4804653 
BMI 1.01 1.00, 1.01 1.01 1.00, 1.02 0.0045 7280.045 1.01 1.00, 1.02 1.01 1.00, 1.02 0.0084 48233686 
Sex      0.0023 7277.307     0.0134 48259742 
Female 1.18 1.01, 1.37 1.52 1.14, 2.01   1.04 0.85, 1.28 1.68 1.19, 2.39   
Male Reference  Reference    Reference  Reference    
Race      < 0.0001 7262.997     0.0002 48087744 
Hispanic 1.10 0.88, 1.37 1.91 1.35, 2.71   1.13 0.84, 1.52 1.69 1.08, 2.65   
NH- Black 1.16 0.92, 1.46 1.38 0.92, 2.09   0.97 0.71, 1.34 1.44 0.85, 2.42   
NH- Asian 0.84 0.58, 1.21 0.31 0.10, 0.97   0.63 0.42, 0.93 0.33 0.10, 1.10   
NH- Other 1.65 1.10, 2.47 3.22 1.83, 5.69   2.01 1.11, 3.66 3.37 1.60, 7.10   
NH- White Reference  Reference    Reference  Reference    
Region      0.0285 7283.900     0.4194 48284313 
South 0.89 0.73, 1.07 0.64 0.46, 0.90   0.95 0.74, 1.22 0.65 0.43, 0.99   
Midwest 0.82 0.66, 1.02 0.57 0.38, 0.85   0.95 0.71, 1.28 0.60 0.36, 0.97   
Northeast 0.94 0.74, 1.19 0.66 0.43, 1.01   0.96 0.71, 1.29 0.69 0.40, 1.19   
West Reference  Reference    Reference  Reference    
Chronic Conditions              
Arthritis 1.54 1.28, 1.85 2.17 1.60, 2.95 < 0.0001 7249.707 1.37 1.09, 1.73 2.38 1.59, 3.55 < 0.0001 48121108 
Asthma 2.12 1.76, 2.56 2.04 1.46, 2.87 < 0.0001 7222.657 1.93 1.50, 2.49 2.21 1.46, 3.34 < 0.0001 47977063 
Cancer 1.39 1.06, 1.83 1.32 0.80, 2.18 0.0400 7283.714 1.19 0.84, 1.68 1.20 0.66, 2.19 0.5278 48326350 
Diabetes 1.71 1.29, 2.26 2.31 1.48, 3.59 < 0.0001 7266.940 1.61 1.09, 2.40 1.99 1.19, 3.34 0.0019 48243809 
CHD 1.31 0.83, 2.06 1.50 0.70, 3.22 0.3180 7287.577 1.30 0.69, 2.44 1.57 0.67, 3.68 0.4424 48322850 
COPD 2.20 1.29, 3.74 5.86 3.17, 10.81 < 0.0001 7262.847 1.60 0.90, 4.26 7.94 3.61, 17.46 < 0.0001 48135419 
Stroke 1.83 1.05, 3.21 3.65 1.76, 7.59 0.0005 7277.747 1.09 0.57, 2.10 2.61 1.12, 6.09 0.0837 48316373 
BMI Classification     < 0.0001 7264.738     0.0090 48115180 
Underweight 1.44 0.74, 2.77 1.26 0.39, 4.04   1.73 0.68, 4.44 1.08 0.30, 3.90   
Overweight 1.19 0.98, 1.43 0.80 0.57, 1.13   1.15 0.87, 1.52 0.73 0.47, 1.15   
Obese 1.59 1.32, 1.93 1.42 1.03, 1.97   1.60 1.21, 2.12 1.25 0.84, 1.88   
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Normal Reference  Reference    Reference  Reference    
The Use of at least one 
Mind-Body Therapy 
    < 0.0001 7262.771     < 0.0001 48091137 
Yes 1.50 1.28, 1.76 1.16 0.88, 1.53   1.60 1.30, 1.98 1.19 0.86, 1.64   
No Reference  Reference    Reference  Reference    
Number of Mind Body 
Therapies Used  
1.12 1.08, 1.16 1.13 1.07, 1.20 < 0.0001 7235.982 1.13 1.08, 1.17 1.14 1.07, 1.22 < 0.0001 47968765 
Most common used Mind 
Body Therapies (Yoga, 
Meditation, Massage, and 
Chiropractic/ Osteopathic) 
1.48 1.27, 1.73 1.26 0.96, 1.67 < 0.0001 7262.441 1.57 1.27, 1.93 1.33 0.97, 1.83 < 0.0001 48097721 
Physical Activity      0.0005 7275.927     0.0080 48201916 
Active 0.67 0.52, 0.86 0.59 0.38, 0.90   0.62 0.42, 0.92 0.52 0.30, 0.90   
Inactive Reference  Reference    Reference  Reference    
Strength Activity            0.0006 48187858 
Active 0.75 0.64, 0.87 0.56 0.42, 0.76 < 0.0001 7261.933 0.78 0.65, 0.95 0.56 0.38, 0.81   
Inactive Reference  Reference    Reference  Reference    
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Table 3: Multinomial Logistic Regression of Depressive Symptoms and the Use of Mind-Body Therapies Adjusted by covariates, 2012 
National Health Interview Survey (NHIS) 
 Unweighted Adjusted Odds Ratio (OR) 
 
Weighted Adjusted Odds Ratio (OR) 
 Moderate vs. Low 
Depressive Symptoms 
High vs. Low 
Depressive Symptoms 
 Moderate vs. Low 
Depressive Symptoms 
High vs. Low 
Depressive Symptoms 
 
Variables Odds 
Ratio 
95% 
Confidence 
Interval 
Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC Odds 
Ratio 
95% 
Confidence 
Interval 
Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC 
Age in years  0.97 0.97, 0.98 0.97 0.96, 0.98 < 0.0001 6987.670 0.97 0.96, 0.98 0.97 0.95, 0.98 < 0.001 42694059 
BMI 1.00 0.99, 1.01 1.00 0.99, 1.01 0.9948  1.01 1.00, 1.02 1.00 0.99, 1.02 0.4441  
Sex      0.2911      0.1429  
Female 1.03 0.87, 1.21 1.27 0.94, 1.71   0.90 0.72, 1.13 1.50 0.96, 2.22   
Male Reference  Reference    Reference  Reference    
Race      0.0018      0.0130  
Hispanic 1.11 0.87, 1.40 1.86 1.28, 2.71   1.13 0.82, 1.56 1.68 1.05, 2.70   
NH- Black 1.14 0.89, 1.46 1.34 0.86, 2.08   0.93 0.66, 1.31 1.34 0.77, 2.36   
NH- Asian 0.96 0.66, 1.41 0.32 0.10, 1.03   0.73 0.49, 1.09 0.36 0.11, 1.19   
NH- Other 1.36 0.90, 2.06 2.50 1.39, 4.51   1.68 0.91, 3.12 2.75 1.27, 5.99   
NH- White Reference  Reference    Reference  Reference    
Region      0.0619      0.3774  
South 0.92 0.75, 1.13 0.64 0.45, 0.91   1.03 0.80, 1.32 0.64 0.42, 0.99   
Midwest 0.81 0.64, 1.02 0.68 0.44, 1.07   0.95 0.71, 1.27 0.59 0.36, 0.97   
Northeast 0.96 0.75, 1.22 0.68 0.44, 1.07   1.03 0.75, 1.42 0.70 0.40, 1.24   
West Reference  Reference    Reference  Reference    
Chronic Conditions              
Arthritis 1.63 1.31, 2.01 2.56 1.78, 3.69 < 0.0001  1.49 1.14, 1.96 2.96 1.76, 4.92 < 0.0001  
Asthma 1.71 1.41, 2.08 1.42 0.99, 2.04 < 0.0001  1.56 1.20, 2.02 1.49 0.96, 2.31 0.0011  
Cancer 1.53 1.14, 2.05 1.28 0.75, 2.21 0.0155  1.48 1.02, 2.16 1.26 0.64, 2.51 0.1127  
Diabetes 1.73 1.27, 2.34 2.13 1.29, 3.52 < 0.0001  1.78 1.15, 2.76 1.87 1.04, 3.37 0.0036  
CHD 1.41 0.86, 2.31 1.29 0.55, 3.02 0.3517  1.63 0.84, 3.13 1.36 0.41, 4.57 0.3226  
COPD 1.76 0.99, 3.13 4.67 2.30, 9.48 < 0.001  1.72 0.74, 4.04 7.05 2.95, 16.97 < 0.0001  
Stroke 1.54 0.86, 2.78 3.14 1.43, 6.92 0.0097  0.85 0.41, 1.77 1.76 0.64, 5.07 0.4683  
BMI Classification     0.0164      0.4059  
Underweight 1.17 0.60, 2.28 0.95 0.29, 3.12   1.39 0.52, 3.71 0.85 0.23, 3.20   
Overweight 1.28 1.05, 1.57 0.81 0.56, 2.28   1.20 0.89, 1.63 0.77 0.46, 1.28   
Obese 1.55 1.21, 1.99 1.15 0.75, 1.76   1.02 0.59, 1.63 1.43 1.02, 2.00   
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Normal Reference  Reference    Reference  Reference    
The Use of at least one 
Mind-Body Therapy 
    0.1569      0.0269  
Yes 1.26 0.83, 1.92 0.40 0.12, 1.27   1.41 0.85, 2.33 0.21 0.06, 0.77   
No Reference  Reference    Reference  Reference    
Number of Mind Body 
Therapies Used  
1.11 1.06, 1.16 1.16 1.07, 1.25 < 0.0001  1.11 1.05, 1.18 1.14 1.05, 1.24 < 0.0001  
Most common used 
Mind Body Therapies 
(Yoga, Meditation, 
Massage, and 
Chiropractic/ Osteopathic) 
0.97 0.64, 1.46 2.06 0.64, 6.63 0.4704  0.96 0.58, 1.58 4.00 1.07, 14.94 0.1197  
Physical Activity      0.0436      0.0627  
Active 0.76 0.59, 0.98 0.71 0.46, 1.10   0.68 0.46, 1.01 0.61 0.34, 1.08   
Inactive Reference  Reference    Reference  Reference    
Strength Activity      < 0.0001      0.0003  
Active 0.73 0.62, 0.86 0.56 0.41, 0.77   0.75 0.62, 0.91 0.56 0.37, 0.83   
Inactive Reference  Reference    Reference  Reference    
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Table 4: Frequency of Individuals with Depressive Symptoms (Two Levels of Depression Symptoms) by Sample Characteristics, 2012 
National Health Interview Survey (NHIS) (N=11,143) 
 Depressive Symptoms 
 
 None/ Low (N= 10232) Moderate/ High (N= 911) Total (N= 11143) 
Variables Unweighted 
Count 
Unweighted 
(%) 
Weighted 
(%) 
Unweighted 
Count 
Unweighted 
(%) 
Weighted 
(%) 
Total Total 
Unweighted 
(%) 
Total 
Weighted 
(%) 
Age in years Mean (SD) 10232 42.78 (16.07) 41.97 911 39.72 (14.50) 38.38 11143 42.53 (15.97) 41.70 
BMI (Mean SD) 10232 28.43 (11.57) 28.34 911 29.76 (12.41) 30.03 11143 28.54 (11.64) 28.46 
Sex          
Female 5162 50.45 47.47 509 55.87 50.79 5671 50.89 47.71 
Male 5070 49.55 52.53 402 44.13 49.21 5472 49.11 52.29 
Race          
NH- White 6775 66.21 71.71 564 61.91 68.78 7339 65.86 71.50 
Hispanic 1389 13.58 12.05 146 16.03 14.20 1535 13.78 12.21 
NH- Black 1235 12.07 9.47 124 13.61 9.62 1359 12.20 9.48 
NH- Asian 577 5.64 4.67 35 3.84 2.71 612 5.49 4.52 
NH- Other 256 2.50 2.09 42 4.61 4.68 298 2.67 2.28 
Region          
South 3500 34.21 34.23 296 32.49 33.05 3796 34.07 34.14 
West 2943 28.76 25.72 303 33.26 28.51 3246 29.13 25.93 
Midwest 2239 21.88 24.43 174 19.10 23.18 2413 21.65 24.34 
Northeast 1550 15.15 15.63 138 15.15 15.26 1688 15.15 15.60 
Chronic Conditions          
Arthritis 1629 15.92 15.11 219 24.04 21.54 1848 16.58 15.58 
Asthma 1200 11.77 11.39 199 21.84 20.38 1399 12.55 12.05 
Cancer 654 6.39 6.29 78 8.56 7.39 732 6.57 6.37 
Diabetes 529 5.17 4.71 83 9.11 7.65 612 5.49 4.92 
CHD  235 2.30 2.28 28 3.07 3.09 263 2.36 2.34 
COPD 107 1.05 0.92 28 3.07 2.77 135 1.21 1.06 
Stroke 112 1.09 1.061 22 2.41 1.46 134 1.20 1.09 
Emphysema 65 0.64 0.62 16 1.76 1.63 81 0.73 0.70 
BMI Classification          
Underweight 123 1.20 1.50 13 1.43 2.05 136 1.22 1.54 
Overweight 3547 34.67 34.57 293 32.16 31.47 3840 34.46 34.34 
Obese 2537 24.79 24.63 299 32.82 32.37 2836 25.45 25.20 
Normal 4025 39.34 39.29 306 33.59 34.11 4331 38.87 38.91 
The Use of at least one Mind-Body 
Therapy 
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Yes 5390 52.68 52.13 557 61.14 62.18 5947 53.37 52.87 
No 4842 47.32 47.87 354 38.86 37.82 5196 46.63 47.13 
Mind- Body Therapies          
Chiropractic/ Osteopathic  3068 29.98 29.79 338 37.10 36.71 3406 30.57 30.29 
Yoga 2344 22.91 22.89 230 25.25 25.50 2574 23.10 23.09 
Massage 2234 21.83 21.23 269 29.53 28.39 2503 22.46 21.76 
Spiritual Meditation * 534 50.71 51.67 96 51.06 50.03 630 50.77 51.43 
Mindfulness Meditation * 427 40.55 40.27 74 39.36 34.75 501 40.37 39.46 
Mantra Meditation * 401 38.08 38.08 86 45.74 39.25 487 39.24 38.25 
Pilates 1201 11.74 11.39 119 13.06 14.74 1320 11.85 11.64 
Acupuncture 808 7.90 7.54 83 9.11 8.64 891 8.00 7.62 
Tai Chi 517 5.05 4.67 60 6.59 5.76 577 5.18 4.75 
Progressive Relaxation * 463 43.97 43.96 95 50.53 49.77 558 44.96 44.82 
Guided Imagery * 418 39.70 40.61 81 43.09 42.05 499 40.21 40.83 
Hypnosis 176 1.72 1.58 40 4.39 4.06 216 1.94 1.76 
Qi Gong 140 1.37 1.10 13 1.43 1.34 153 1.37 1.11 
Biofeedback 127 1.24 1.23 32 3.51 3.03 159 1.43 1.36 
Alexander Technique 56 0.55 0.52 7 0.77 0.72 63 0.57 0.54 
Trager Psychophysical 
Integration 
22 0.22 
 
0.17 4 0.44 0.33 26 0.23 0.18 
Number of Mind Body Therapies 
Used 
         
0 4853 47.35 47.85 356 38.91 37.78 5209 46.65 47.11 
1 2376 23.18 23.49 204 22.30 24.11 2580 23.11 23.54 
2 1330 12.98 12.60 115 12.57 11.87 1445 12.94 12.55 
3+ 1691 16.50 16.06 240 26.23 26.23 1931 17.30 16.81 
Most common used Mind Body 
Therapies (Yoga, Meditation, 
Massage, and Chiropractic/ 
Osteopathic) 
 
5020 
 
48.98 
 
48.69 
 
529 
 
57.81 
 
58.97 
 
5549 
 
49.70 
 
49.45 
Physical Activity          
Active  9482 92.51 92.39 813 88.85 87.92 10295 92.21 92.06 
Inactive  768 7.49 7.611 102 11.15 12.07 870 7.79 7.94 
Strength Activity          
Active  4454 43.45 44.40 322 35.19 36.96 4776 42.78 43.86 
Inactive 5796 56.55 55.60 593 64.81 63.04 6389 57.22 56.14 
* Survey Questions for meditations and guided imagery had missing value 
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Table 5: Unadjusted Binomial Logistic Regression of Depressive Symptoms and the Use of Mind-Body Therapies, 2012 National 
Health Interview Survey (NHIS) 
 Unweighted Unadjusted Odds Ratio (OR) 
 
Weighted Unadjusted Odds Ratio (OR) 
Variables Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC 
Age in years  0.99 0.98, 0.99 < 0.0001 6280.244 0.99 0.98, 0.99 < 0.0001 42158307 
BMI 1.01 1.00, 1.01 0.0010 6302.096 1.01 1.00, 1,02 0.0021 42348262 
Sex    0.0017 6301.866   0.1468 42424872 
Female 1.24 1.09, 1.43   1.14 0.95, 1.37   
Male Reference        
Race    < 0.001 6293.195   0.0003 42245015 
Hispanic 1.26 1.04, 1.53   1.23 0.96, 1.58   
NH- Black 1.21 0.98, 1.48   1.06 0.79, 1.42   
NH- Asian 0.73 0.51, 1.04   0.58 0.39, 0.85   
NH- Other 1.97 1.41, 2.76   2.26 1.37, 3.72   
NH- White Reference    Reference    
Region    0.0234 6306.323   0.6241 42429808 
South 0.82 0.70, 0.97   0.88 0.70, 1.10   
Midwest 0.76 0.62, 0.92   0.87 0.67, 1.13   
Northeast 0.87 0.70, 1.07   0.89 0.69, 1.16   
West Reference    Reference    
Chronic Conditions          
Arthritis 1.67 1.42, 1.96 < 0.0001 6275.413 1.55 1.27, 1.89 < 0.0001 42285779 
Asthma 2.10 1.78, 2.49 < 0.0001 6244.740 1.98 1.59, 2.48 < 0.0001 42091304 
Cancer 1.37 1.07, 1.75 0.0114 6305.794 1.19 0.88, 1.62 0.2603 42437863 
Diabetes 1.84 1.44, 2.34 < 0.0001 6290.285 1.69 1.22, 2.34 0.0018 42358503 
CHD 1.35 0.91, 2.01 0.1395 6309.716 1.36 0.79, 2.32 0.2665 42435419 
COPD 3.00 1.97, 4.58 < 0.0001 6290.743 3.09 1.76, 5.41 < 0.0001 42318216 
Stroke 2.24 1.41, 3.55 0.0006 6301.976 1.39 0.82, 2.35 0.2183 42441418 
BMI Classification   < 0.0001 6286.882   0.0019 42258888 
Underweight 1.39 0.78, 2.49   1.58 0.69, 3.62   
Overweight 1.09 0.92, 1.28   1.05 0.83, 1.33   
Obese 1.55 1.31, 1.83   1.52 1.19, 1.94   
Normal Reference    Reference    
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The Use of at least one 
Mind-Body Therapy 
  < 0.0001 6287.408   < 0.0001 42222799 
Yes 1.41 1.23, 1.62   1.51 1.26, 1.81   
No Reference    Reference    
Number of Mind Body 
Therapies Used  
1.12 1.09, 1.16 < 0.0001 6258.184 1.13 1.09, 1.17 < 0.0001 42081132 
Most common used Mind 
Body Therapies (Yoga, 
Meditation, Massage, and 
Chiropractic/ Osteopathic) 
1.43 1.25, 1.64 < 0.0001 6285.462 1.51 1.27, 1.81 < 0.0001 42215494 
Physical Activity    0.0001 6298.266   0.0033 42316574 
Active 0.65 0.52, 0.81   0.60 0.43, 0.84   
Inactive Reference    Reference    
Strength Activity    < 0.0001 6286.860   0.0004 42323445 
Active 0.70 0.61, 0.81   0.73 0.62, 0.87   
Inactive Reference    Reference    
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Table 6: Binomial Logistic Regression of Depressive Symptoms and the Use of Mind-Body Therapies Adjusted by covariates, 2012 
National Health Interview Survey (NHIS) 
 Unweighted Adjusted Odds Ratio (OR) 
 
Weighted Adjusted Odds Ratio (OR) 
Variables Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value AIC 
Age in years  0.97 0.97, 0.98 < 0.0001 6010.051 0.97 0.96, 0.98 < 0.0001 40212488 
BMI 1.00 0.99, 1.01 0.9850  1.01 1.00, 1.01 0.2342  
Sex    0.3338    0.9348  
Female 1.08 0.93, 1.25   0.99 0.81, 1.21   
Male Reference    Reference    
Race    0.0084    0.0137  
Hispanic 1.26 1.03, 1.55   1.23 0.94, 1.61   
NH- Black 1.18 0.95, 1.47   1.01 0.74, 1.38   
NH- Asian 0.82 0.57, 1.18   0.66 0.44, 0.97   
NH- Other 1.60 1.13, 2.27   1.88 1.12, 3.18   
NH- White Reference    Reference    
Region    0.0488    0.7559  
South 0.85 0.71, 1.01   0.94 0.75, 1.17   
Midwest 0.76 0.62, 0.93   0.87 0.67, 1.12   
Northeast 0.89 0.71, 1.10   0.95 0.71, 1.27   
West Reference    Reference    
Chronic Conditions          
Arthritis 1.80 1.49, 2.18 < 0.0001  1.72 1.36, 2.17 < 0.0001  
Asthma 1.65 1.38, 1.97 < 0.0001  1.55 1.23, 1.95 0.0002  
Cancer 1.47 1.13, 1.92 0.0048  1.23 1.02, 2.01 0.0394  
Diabetes 1.82 1.39, 2.38 < 0.0001  1.81 1.26, 2.59 0.0015  
CHD 1.37 0.88, 2.13 0.1658  1.54 0.85, 2.79 0.1545  
COPD 2.38 1.48, 3.82 0.0003  2.70 1.45, 5.03 0.0018  
Stroke 1.87 1.14, 3.07 0.0135  1.03 0.56, 1.92 0.9189  
BMI Classification   0.0121    0.2542  
Underweight 1.11 0.61, 2.01   1.25 0.52, 3.01   
Overweight 1.16 0.97, 1.39   1.10 0.85, 1.43   
Obese 1.45 1.16, 1.80   1.33 1.00, 1.78   
Normal Reference    Reference    
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The Use of at least one 
Mind-Body Therapy 
  0.8472    0.6361  
Yes 1.04 0.70, 1.55   1.12 0.69, 1.83   
No Reference    Reference    
Number of Mind Body 
Therapies Used  
1.12 1.07, 1.16 < 0.0001  1.12 1.06, 1.18 < 0.0001  
Most common used 
Mind Body Therapies 
(Yoga, Meditation, 
Massage, and 
Chiropractic/ 
Osteopathic) 
1.07 0.72, 1.59 0.7353  1.09 0.69, 1.75 0.7074  
Physical Activity    0.0132    0.0242  
Active 0.75 0.60, 0.94   0.67 0.47, 0.95   
Inactive Reference    Reference    
Strength Activity    < 0.0001    < 0.0001  
Active 0.69 0.60, 0.80   0.71 0.60, 0.84   
Inactive Reference    Reference    
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Table 7: Generalized Linear Mixed Models with Depressive Symptoms and the Use of Mind-Body Therapies with Clustering by 
Region, 2012 National Health Interview Survey (NHIS) 
 Unweighted Unadjusted 
Generalized Linear Mixed Model 
 
Unweighted Adjusted 
Generalized Linear Mixed Model 
 
Variables Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value Odds 
Ratio 
95% 
Confidence 
Interval 
P-Value 
Age in years  0.99 0.98, 0.99 < 0.0001 0.97 0.97, 0.98 < 0.0001 
BMI 1.01 1.00, 1.01 0.0168 1.00 0.99, 1.01 0.9991 
Sex    0.1196   0.3509 
Female 1.23 1.05, 1.45  1.08 0.93, 1.25  
Male Reference   Reference   
Race    0.0056   0.0055 
Hispanic 1.22 0.98, 1.53  1.26 1.03, 1.55  
NH- Black 1.20 0.95, 1.53  1.18 0.95, 1.47  
NH- Asian 0.75 0.51, 1.12  0.82 0.57, 1.18  
NH- Other 1.84 1.21, 2.78  1.60 1.13, 2.27  
NH- White Reference   Reference   
Chronic Conditions        
Arthritis 1.60 1.32, 1.94 < 0.0001 1.80 1.49, 2.18 < 0.0001 
Asthma 2.02 1.65, 2.47 < 0.0001 1.65 1.38, 1.97 < 0.0001 
Cancer 1.30 0.97, 1.74 0.0788 1.47 1.13, 1.92 0.0044 
Diabetes 1.67 1.25, 2.26 0.0006 1.82 1.39, 2.38 < 0.0001 
CHD 1.33 0.83, 2.13 0.2402 1.37 0.88, 2.13 0.1713 
COPD 2.88 1.69, 4.90 0.0001 2.38 1.48, 3.82 0.0004 
Stroke 2.06 1.16, 3.66 0.0134 1.87 1.14, 3.07 0.0139 
BMI Classification   0.0006   0.0135 
Underweight 1.48 1.21, 1.79  1.11 0.61, 2.01  
Overweight 1.06 0.88, 1.29  1.16 0.97, 1.39  
Obese 1.48 1.21, 1.74  1.45 1.16, 1.80  
Normal Reference   Reference   
The Use of at least one Mind-
Body Therapy 
  0.0003   0.8579 
Yes 1.35 1.15, 1.58  1.04 0.70, 1.55  
No Reference   Reference   
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Number of Mind Body 
Therapies Used  
1.31 1.07, 1.15 < 0.0001 1.12 1.07, 1.16 < 0.0001 
Most common used Mind 
Body Therapies (Yoga, 
Meditation, Massage, and 
Chiropractic/ Osteopathic) 
1.37 1.17, 1.60 0.0001 1.07 0.72, 1.59 0.7280 
Physical Activity    0.0037   0.0135 
Active 0.68 0.52, 0.88  0.75 0.60, 0.94  
Inactive Reference   Reference   
Strength Activity    0.0001   < 0.0001 
Active 0.73 0.62, 0.86  0.69 0.60, 0.80  
Inactive Reference   Reference   
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